The University of California has been on the front lines in the fight against SARS-CoV-2, the virus that causes COVID-19 (coronavirus), since the earliest indications of its emergence late last year.
UC’s five academic medical centers — including UCI — all have significant expertise in treating infectious diseases and have instituted standard protocols and other measures to prevent the potential spread of the virus.
UCI Health Executive Vice President and infectious disease expert, Dr. Carrie Byington, issued a statement on March 11th that read, “As the nation’s leading academic health system, it is our duty and privilege to marshal UC’s incredible breadth of health and research expertise against this emerging disease. Whether it’s in our hospitals, laboratories, or classrooms, UC’s scientists and faculty are rising to the challenge of protecting communities across California and the nation during this difficult time.”
On March 23rd, UCI announced that UCI Health clinicians have launched a clinical trial to test the efficacy of the antiviral drug remdesivir as a potential therapy for COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2) that has reached pandemic levels across the globe. To read more about the clinical trial, click here.
UCI infectious disease experts are also assisting with statewide and national efforts to track the outbreak and contain the spread of the coronavirus.
UCI Health is working closely with the Centers for Disease Control and Prevention (CDC), the California Department of Public Health (CDPH) and the Orange County Health Care Agency (HCA).
To learn the very latest from UCI, click here.